本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

5.30
-0.1500-2.75%
成交量:6.95万
成交额:36.65万
市值:3,240.58万
市盈率:-0.25
高:5.59
开:5.43
低:5.10
收:5.45
数据加载中...
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/27

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/02

重要事件披露

8-K - Current report
2022/11/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/27

重要事件披露

8-K - Current report
2022/05/04

重要事件披露

8-K - Current report
2022/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/30

重要事件披露

8-K - Current report
2022/03/22

重要事件披露

8-K - Current report
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals